Navigation Links
Bode Technology Announces Forensic Genealogy Service to Law Enforcement Agencies and Crime Laboratories
Date:2/11/2019

Bode Technology (Bode), a leading provider of forensic DNA analysis products and services, announced a new forensic genealogy service offering to law enforcement investigators and crime laboratories. Bode’s Forensic Genealogy Service (FGS) combines advanced DNA testing and genealogy to develop ancestral relationships between samples and deliver leads to our clients.

For more than 20 years, Bode has provided forensic DNA testing services for clients across the world to identify perpetrators of crimes, identify the missing and exonerate the innocent. The results are entered into the national DNA database and investigative leads are developed from the matches within the database, however not all samples result in matches.

“It is estimated that 50% of the samples entered into the national database do not result in matches, nor support investigations,” said Mike Cariola, President and CEO of Bode Technology. “Over the past three years alone, Bode has processed nearly 50,000 sexual assault kits. Every one of these cases that goes unmatched, thus unsolved in CODIS, is a candidate for forensic genealogy. Victims deserve justice and perpetrators need to be caught before they commit more crimes.”

Bode’s FGS program is a logical expansion of its service offerings to support the law enforcement community. By incorporating Bode’s accredited forensic laboratory, accredited clinical testing laboratories, and board certified and experienced genealogists, Bode has developed a high-quality, turn-key solution for our clients from sample submission through confirmation testing.

“Bode’s history is built on providing quality services to our clients and helping victims of crime seek justice. Offering advanced DNA testing services is the next step to identifying more investigative leads and delivering a positive impact on public safety,” said Andrew Singer, Director of Sales and Marketing. “Our first case processed has already helped identify a likely perpetrator of a nearly 20-year old cold case homicide.”

Bode provides forensic accredited DNA services for sample handling, extraction and confirmation testing. Bode has partnered with an accredited laboratory for SNP testing and board certified and experienced genealogists to perform the genealogy research.

About Bode Technology

Bode operates one of the most internationally respected private forensic DNA laboratories and provides a comprehensive set of state-of-the-art forensic DNA collection products, DNA analysis services, and research services to law enforcement, the justice system and other government agencies around the world. Bode is one of the few private facilities worldwide to receive ISO/IEC 17025 accreditation from both the American Society of Crime Laboratory Directors/ Laboratory Accreditation Board (ASCLD/LAB-International Program) and the ANSI-ASQ National Accreditation Board/FQS for forensic testing.

Read the full story at https://www.prweb.com/releases/bode_technology_announces_forensic_genealogy_service_to_law_enforcement_agencies_and_crime_laboratories/prweb16091796.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes
2. RoosterBio Inc. and Tissue Regeneration Therapeutics Inc. Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology
3. SF Bay Cosmetic Body Sculpting Introduces A Safe And Non-Surgical Butt Lift With Innovative New Technology, Emsculpt®
4. Abbott Diagnostics Features Advanced Optical Hematology Technology for Elevated Analytical Performance, in Informative Webinar
5. Mitotech Initiates Phase 3 Clinical Trial of SkQ1 Ophthalmic Solution in Patients with Dry Eye Disease in a Co-Development Effort with Essex Bio-Technology
6. Orbita Takes Steps to Drive Innovation in Conversational AI and Voice Technology Solutions for Health Care
7. Cell Signaling Technology Discusses Challenges and Opportunities of Post-translational Modifications and Data-Independent Acquisitions in Educational Webinar
8. Diagenode Gains Exclusive Rights to New ChIPmentation Technology for Chromatin Immunoprecipitation with High Throughput Sequencing
9. Cell Signaling Technology Explores Mechanisms of Myeloid Immunosuppression in Educational Webinar
10. Journal Cell Features New Immunohistochemistry Imaging Technology from IONpath that Images 40+ Proteins on a Single Slide
11. Dickinson Wright Attorney Lance Anderson Named Pharmaceuticals and Biotechnology Practice Group Chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2019)... ... ... Boston-based Laboratory as a Service (LaaS) leader, Mass Innovation Labs, has changed its ... and service offerings for biotech and life sciences companies. , “Meeting the ... agile and adaptable than ever before. One that doubles-down on the things that matter ...
(Date:1/10/2019)... ... January 09, 2019 , ... Dr. Beanlands is the ... in Ottawa, Ontario, Canada. He is also Director of its National Cardiac PET ... in the Department of Radiology, and in the Department of Cellular and Molecular medicine. ...
(Date:1/8/2019)... ... January 07, 2019 , ... Join industry experts Julie ... a live webinar on Thursday, January 17, 2019 at 1pm EST. ... of risk during the clinical trial process. Featured speakers will also present a case ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... ... 11, 2019 , ... Drawing on over 22 years of software development expertise, ... EST will explore some of the key lessons that have driven customer satisfaction with ... multiple vendors, and find out how to ensure that you continue to be able ...
(Date:1/10/2019)... ... January 08, 2019 , ... ... spinal implant company, announced today that SAGICO will be represented at the ... annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare ...
(Date:1/8/2019)... (PRWEB) , ... January 07, 2019 , ... ... of its members into Noninvasix. This represents the second investment AngelMD has made ... mortality and morbidity, Noninvasix is developing a patient monitor to directly, accurately, and ...
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today ... drug candidate, code-named "KM-819." KM-819 is an orally active small molecule that ... South Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was ...
Breaking Biology Technology: